Management of Recurrent Seizures in Patients on Antiepileptic Medications

Rationale for Lorazepam Administration

• Benzodiazepines, including lorazepam, are the first-line treatment for active seizures in patients on antiepileptic medications like Depakote and barbiturates 1
• The American College of Emergency Physicians provides a Level A recommendation for administering additional antiepileptic medication in patients with refractory seizures 2
• Patients experiencing recurrent seizures within a short interval may be at risk of progressing to status epilepticus, requiring immediate intervention 1, 3

Post-Administration Management

• For refractory seizures after benzodiazepine administration, consider IV valproate, phenytoin, or fosphenytoin (Level B recommendation) 1, 2
• If seizures persist, consider levetiracetam, propofol, or additional barbiturates (Level C recommendation) 1, 2

Monitoring and Follow-up

• Check antiepileptic drug serum levels to ensure therapeutic ranges after seizure cessation 1
• Evaluate for potential triggers such as metabolic disturbances, drug toxicity, infection, or CNS pathology 3
• Consider EEG monitoring if available, particularly if mental status does not return to baseline 1

Common Pitfalls to Avoid

• Withholding benzodiazepines due to concerns about multiple anticonvulsants can increase the risk of status epilepticus morbidity and mortality 1, 3
• Administering phenytoin or fosphenytoin as first-line therapy before benzodiazepines has shown limited success in terminating status epilepticus 4